{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/17/3313482/0/en/Connect-Biopharma-Announces-Completion-of-Enrollment-of-Phase-2-Seabreeze-STAT-Asthma-Study-Evaluating-Rademikibart-for-the-Treatment-of-Acute-Exacerbations-in-Asthma.html", "message": "News view counter 804449 successfully enlarged"}